Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Elashoff

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
American Journal of Public Health|July 15, 1998
Significance of workplace smokingL Breslow, R Elashoff
Transplantation|February 3, 1998
Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantationM W Cavaillé-Coll, M R Elashoff
Advances in Metabolic Disorders|January 1, 1973
Progress report on the prophylactic use of oral hypoglycemic drugs in asymptomatic diabetes: neurovascular studiesR Feldman, D Crawford, R Elashoff, et al.
Transplantation|October 3, 1999
A commentary on a randomized active-controlled trial of mycophenolate mofetil in heart transplant recipientsJ A Korvick, M R Elashoff, M Cavaillé-Coll
Revue Internationale Du Trachome. International Review of Trachoma|January 1, 1972
[The evaluation of controlled trachoma chimiotherapy trial]C R Dawson, R Elashoff, L Hanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Improved survival for patients with AIDS-related Kaposi's sarcomaS A Miles, H Wang, R Elashoff, et al.
Human Pathology|April 4, 2000
Individualized prognosis for melanoma patientsA J Cochran, D Elashoff, D L Morton, et al.
International Journal of Obesity (2005)|February 16, 2005
Analysis of weight loss outcomes using VLCD in black and white overweight and obese women with and without metabolic syndromeK Hong, Z Li, H-J Wang, et al.
Annals of Surgical Oncology|November 24, 1999
Increased incidence of second primary melanoma in patients with a previous cutaneous melanomaL A DiFronzo, L A Wanek, R Elashoff, et al.
Cancer Research|December 26, 2001
Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced featuresD Xie, K Nakachi, H Wang, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Public Health|July 15, 1998
Significance of workplace smokingL Breslow, R Elashoff
Transplantation|February 3, 1998
Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantationM W Cavaillé-Coll, M R Elashoff
Advances in Metabolic Disorders|January 1, 1973
Progress report on the prophylactic use of oral hypoglycemic drugs in asymptomatic diabetes: neurovascular studiesR Feldman, D Crawford, R Elashoff, et al.
Transplantation|October 3, 1999
A commentary on a randomized active-controlled trial of mycophenolate mofetil in heart transplant recipientsJ A Korvick, M R Elashoff, M Cavaillé-Coll
Revue Internationale Du Trachome. International Review of Trachoma|January 1, 1972
[The evaluation of controlled trachoma chimiotherapy trial]C R Dawson, R Elashoff, L Hanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Improved survival for patients with AIDS-related Kaposi's sarcomaS A Miles, H Wang, R Elashoff, et al.
Human Pathology|April 4, 2000
Individualized prognosis for melanoma patientsA J Cochran, D Elashoff, D L Morton, et al.
International Journal of Obesity (2005)|February 16, 2005
Analysis of weight loss outcomes using VLCD in black and white overweight and obese women with and without metabolic syndromeK Hong, Z Li, H-J Wang, et al.
Annals of Surgical Oncology|November 24, 1999
Increased incidence of second primary melanoma in patients with a previous cutaneous melanomaL A DiFronzo, L A Wanek, R Elashoff, et al.
Cancer Research|December 26, 2001
Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced featuresD Xie, K Nakachi, H Wang, et al.
Pageof 7